Dr. Graham Cope

Dr. Graham Cope is a toxicologist with over 30 years of experience, specializing in tobacco and alcohol related diseases. As part of his smoking-related research he developed a rapid, point of care test for cotinine to monitor nicotine intake. This led to formation of GFC Diagnostics Ltd and the further adaptation of the testing device to incorporate assays to monitor drug adherence for treatment of tuberculosis and leprosy. His interest in antimicrobial resistance led him to work on a point of care test for the rapid diagnosis of antimicrobial strains of bacteria.